Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Bendamustine/ganciclovir/rituximab

Cytomegalovirus retinitis and worsening neutropenia

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Lee S, et al. Cytomegalovirus Retinitis With Combination Therapy of Bendamustine and Rituximab for Waldenstrom Macroglobulinemia. American Journal of Respiratory and Critical Care Medicine 207: Jan 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.B25 [abstract] Lee S, et al. Cytomegalovirus Retinitis With Combination Therapy of Bendamustine and Rituximab for Waldenstrom Macroglobulinemia. American Journal of Respiratory and Critical Care Medicine 207: Jan 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.B25 [abstract]
Metadaten
Titel
Bendamustine/ganciclovir/rituximab
Cytomegalovirus retinitis and worsening neutropenia
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-53957-7

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Prednisone

Case report

Cadi-05

Case report

Vancomycin